查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433292

全球病患登記軟體市場 2023-2030

Global Patient Registry Software Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

在預測期內（2023-2030年），全球病患登記軟體市場預計將以 8.6%的CAGR成長。該市場的成長歸功於全球以患者為中心的照護。除了患者倡導團體的參與之外，涵蓋患者報告的結果測量也反映了以患者為中心的護理日益成長的趨勢。這一轉變得到了患者登記軟體的幫助，該軟體捕捉患者的觀點和經驗。根據美國國立衛生研究院的資料，2023年 5月，患者登記涵蓋了廣泛的疾病領域，其中重點是歐洲。 92%的登記處涵蓋了臨床患者，81%的登記處獲得了知情同意，76%的登記處保護了收集到的資料。 57%的註冊中心收集了患者報告的結果指標，38%在註冊中心設計過程中諮詢了 PAG，51%報告了品質管理細節，46%報告了維護細節。

細分市場前景

全球患者登記軟體市場按登記類型、軟體類型、部署和最終用戶進行細分。根據註冊類型，市場分為特定疾病註冊、健康服務註冊和產品註冊。根據軟體類型，市場分為獨立軟體和整合軟體。根據部署，市場分為本地和雲端。此外，根據最終用戶，市場又細分為醫院和衛生系統、政府組織和第三方管理機構（TPA）、製藥、生物技術和醫療器材公司等。政府組織和第三方管理機構（TPA）子類別預計將佔據最終用戶細分市場的很大一部分市場佔有率。這歸因於製藥、生物技術和醫療器材公司數量的增加，這主要是由於對製藥和生物技術產品的需求增加。

預計特定疾病登記子細分市場將在全球病患登記軟體市場中佔據相當大的佔有率

在註冊類型中，特定疾病註冊細分市場預計將在全球患者註冊軟體市場中佔據相當大的佔有率。根據 BMC 的說法，2022年 4月，疾病登記系統是一個用於收集、分析和報告特定人群患有相同病症的患者資料的資訊系統。它可用於醫療保健評估、發病率和盛行率估計、監測護理品質、提供回饋、觀察疾病的自然病程、監測臨床安全性以及評估疾病負擔、健康結果和成本。

區域展望

全球病患登記軟體市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於慢性病的嚴重流行以及該地區進行的治療手術數量的增加，預計北美將在全球市場中佔據顯著佔有率。

歐洲地區全球病患登記軟體市場預計將以顯著的CAGR成長

在所有地區中，歐洲地區預計在預測期內將以相當大的CAGR成長。區域成長歸因於該地區罕見疾病宣傳的不斷加強。對罕見疾病宣傳和認知的日益重視凸顯了孤兒病患者未得到滿足的醫療需求。患者登記處透過收集有關患者體驗的真實資料來幫助實現這些目標。根據 Frontiers 報道，2022年 8月，歐洲藥品管理局（EMA）評估的所有上市許可申請中，有 26.8%包括所謂的孤兒藥產品，這些產品目的是治療、預防或促進診斷危及生命或慢性衰弱的疾病，但在歐盟（EU），盛行率低於萬分之五。由於患者群體小且異質性，這些藥物往往受到有限的臨床證據的影響，而患者登記已被確定為應對這一挑戰並提供資料以支持監管決策的潛在方法。病患登記是一個有組織的系統，用於收集和組織患有某種疾病、狀況或暴露的人群的特定健康結果的資料。

市場參與者展望

服務全球病患登記軟體市場的主要公司包括 Dacima Software, Inc.、DSG, Inc.、FIGmd Inc.、Global Vision Technologies Image Trend Inc.、LexisNexis group、IBM Corp. 等。市場參與者透過各種策略（包括併購、夥伴關係、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022年 4月，Quantori, LLC 推出了註冊科學實務。重點是為患者、醫生和研究人員開發註冊計劃。登記科學是醫學資訊學和生物統計學的新興領域，它將醫學和流行病學結合起來，追蹤長期健康結果並改善實證護理服務。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 在全球病患登記軟體市場中營運的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。透過識別市場中「誰的立場」來制定競爭策略。

目錄

第1章 報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依細分
    • 依地區

第2章 市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第3章 競爭格局

  • 主要公司分析
  • Apixo, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • ArborMetrix
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Cerner Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第4章 市場細分

  • 按登記類型分類的全球病患登記軟體市場
    • 特定疾病登記處
    • 健康服務登記處
    • 產品註冊
  • 依軟體類型分類的全球病患登記軟體市場
    • 獨立軟體
    • 整合軟體
  • 依部署分類的全球病患登記軟體市場
    • 本地部署
    • 雲端
  • 依最終使用者分類的全球病患登記軟體市場
    • 醫院和衛生系統
    • 政府組織和第三方管理員（TPA）
    • 製藥、生技和醫療器材公司
    • 其他（學術和研究機構、健康保險提供者）

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第6章 公司簡介

  • Dacima Software, Inc.
  • DSG, Inc.
  • FIGmd Inc.
  • Global Vision TechnologiesImage Trend Inc.
  • Health Catalyst
  • IBM Corp.
  • IQVIA Inc.
  • Liaison Technology Group
  • McKesson Corp.
  • Open Text Corp.
  • Optum, Inc.
  • Ordinal Data, Inc.
  • Syneos Health
  • Velos Inc.
Product Code: OMR2027928

Global Patient Registry Software Market Size, Share & Trends Analysis Report by Type of Registry (Disease-Specific Registries, Health Service Registries, and Product Registries), by Type of Software (Stand-Alone Software, and Integrated Software), by Deployment (On-Premises, and Cloud), and by End-User (Hospitals and Health Systems, Government Organizations, and Third Party Administrators (TPAs), Pharmaceutical, Biotechnology, and Medical Device Companies, and Others) Forecast Period (2023-2030)

The global patient registry software market is anticipated to grow at a CAGR of 8.6% during the forecast period (2023-2030). The market's growth is attributed to patient-centered care across the globe. The inclusion of patient-reported outcome measures, in addition to the participation of patient advocacy groups, reflects an increasing tendency toward patient-centered care. This transition is aided by patient registry software, that captures patient viewpoints and experiences. According to the National Institute of Health, in May 2023,patient registries covered a wide range of disease areas, with a focus on Europe. 92% of the registries included clinical patients, 81% obtained informed consent, and 76% protected the collected data. 57% of the registries collected patient-reported outcome measures, 38% consulted PAGs during the registry design process, 51% reported quality management details, and 46% reported maintenance details.

Segmental Outlook

The global patient registry software market is segmented on the type of registry, type of software, deployment, and end user. Based on the type of registry, the market is sub-segmented into disease-specific registries, health service registries, and product registries. Based on the type of software, the market is sub-segmented into stand-alone software, and integrated software. Based on the deployment, the market is sub-segmented into on-premises, and cloud. Further, on the basis of end-user, the market is sub-segmented into hospitals and health systems, government organizations and third-party administrators (TPAs), pharmaceutical, biotechnology, and medical device companies, and others. The government organizations and third party administrators (TPAs) subcategory is expected to capture a significant portion of the market share within the end-user segment. This is attributed to the number of pharmaceutical, biotechnology, and medical device companies has increased, owing essentially to increased demand for pharmaceutical and biotechnology products.

The Disease-specific Registries Sub-Segment is Anticipated to Hold a Considerable Share of the Global Patient Registry Software Market

Among the type of registry, the disease-specific registries sub-segment is expected to hold a considerable share of the global patient registry software market. According to the BMC, in April 2022, a disease registry system is an information system used for collecting, analyzing, and reporting data about a certain population of patients with the same condition. It can be used for healthcare evaluation, estimation of incidence and prevalence, monitoring the quality of care, providing feedback, observing the natural course of diseases, monitoring clinical safety, and assessing disease burden, health outcomes, and costs.

Regional Outlook

The global patient registry software market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the significant prevalence of chronic diseases, in addition to an increase in the number of therapeutic operations conducted in the region.

The Europe Region is Expected to Grow at a Significant CAGR in the Global Patient Registry Software Market

Among all regions, the Europe regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising rare disease advocacy in the region. The growing emphasis on rare disease advocacy and awareness has highlighted to light the unmet medical requirements of patients suffering from orphan diseases. Patient registries help to accomplish these objectives by collecting real-world data on patient experiences. According to the Frontiers, in August 2022, 26.8% of all the marketing authorization applications assessed by the European Medicines Agency (EMA) were for so-called orphan medicinal products, that are meant to treat, prevent or facilitate diagnosis of diseases that are life-threatening or chronically debilitating, but have a prevalence of less than 5 in 10,000 in the European Union (EU). These medicines are often subject to limited clinical evidence owing to their small and heterogeneous patient populations, and patient registries have been identified as a potential way to address this challenge and provide data to support regulatory decision-making. A patient registry is an organized system that collects and organizes data on specified health outcomes for a population with a certain disease, condition or exposure.

Market Players Outlook

The major companies serving the global patient registry software market include Dacima Software, Inc., DSG, Inc., FIGmd Inc., Global Vision Technologies Image Trend Inc., LexisNexis group, IBM Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Quantori, LLC, launched a Registry Science Practice. That focused on the development of registry programs for patients, physicians, and researchers. Registry Science is an emerging area of medical informatics and biostatistics that combines medicine and epidemiology to track long-term health outcomes and improve evidence-based care delivery.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global patient registry software market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Apixo, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. ArborMetrix
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Cerner Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Patient Registry Software Market by Type of Registry
    • 4.1.1. Disease-specific Registries
    • 4.1.2. Health Service Registries
    • 4.1.3. Product Registries
  • 4.2. Global Patient Registry Software Market by Type of Software
    • 4.2.1. Stand-alone Software
    • 4.2.2. Integrated Software
  • 4.3. Global Patient Registry Software Market by Deployment
    • 4.3.1. On-Premises
    • 4.3.2. Cloud
  • 4.4. Global Patient Registry Software Market by End-User
    • 4.4.1. Hospitals and Health Systems
    • 4.4.2. Government Organizations and Third Party Administrators (TPAs)
    • 4.4.3. Pharmaceutical, Biotechnology, and Medical Device Companies
    • 4.4.4. Others (Academic and Research Institutions, and Health Insurance Providers)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Dacima Software, Inc.
  • 6.2. DSG, Inc.
  • 6.3. FIGmd Inc.
  • 6.4. Global Vision TechnologiesImage Trend Inc.
  • 6.5. Health Catalyst
  • 6.6. IBM Corp.
  • 6.7. IQVIA Inc.
  • 6.8. Liaison Technology Group
  • 6.9. McKesson Corp.
  • 6.10. Open Text Corp.
  • 6.11. Optum, Inc.
  • 6.12. Ordinal Data, Inc.
  • 6.13. Syneos Health
  • 6.14. Velos Inc.

LIST OF TABLES

  • 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
  • 2. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL HEALTH SERVICE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PRODUCT PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 6. GLOBAL STAND-ALONE SOFTWARE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL INTEGRATED SOFTWARE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 9. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON-PREMISES RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON CLOUD REVIEW AND MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 12. GLOBAL PATIENT REGISTRY SOFTWARE FOR HOSPITALS AND HEALTH SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PATIENT REGISTRY SOFTWARE FOR GOVERNMENT ORGANIZATIONS AND THIRD PARTY ADMINISTRATORS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL PATIENT REGISTRY SOFTWARE FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL PATIENT REGISTRY SOFTWARE FOR OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT , 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 22. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
  • 24. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 25. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 26. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY , 2022-2030 ($ MILLION)
  • 29. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 30. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 31. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY , 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT , 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY TYPE OF REGISTRY, 2022 VS 2030 (%)
  • 2. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL HEALTH SERVICE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PRODUCT PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY TYPE OF SOFTWARE, 2022 VS 2030 (%)
  • 6. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL HEALTH SERVICE RESPITE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL PRODUCT RESPITE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY DEPLOYMENT, 2022 VS 2030 (%)
  • 10. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON-PREMISES RESEARCH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON CLOUD REVIEW AND MANAGEMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 13. GLOBAL PATIENT REGISTRY SOFTWARE FOR HOSPITALS AND HEALTH SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL PATIENT REGISTRY SOFTWARE FOR GOVERNMENT ORGANIZATIONS AND THIRD PARTY ADMINISTRATORS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL PATIENT REGISTRY SOFTWARE FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL PATIENT REGISTRY SOFTWARE FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. US PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CANADA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. UK PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. FRANCE PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. GERMANY PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. ITALY PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SPAIN PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. INDIA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. CHINA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. JAPAN PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)